Proteome Sciences — TickStock

Proteome Sciences is a UK-based contract research organization specializing in applied proteomics and protein biomarker discovery, validation, and assay development for pharmaceutical, biotechnology, diagnostics, and academic clients. The company manufactures proprietary isobaric mass spectrometry reagents (TMT and TMTpro tags) distributed globally through Thermo Fisher, while providing outsourced proteomics services including sample analysis, bioinformatics, and targeted assays under ISO 9001:2015 and GCLP certifications. Listed on AIM, the company operates with a portfolio exceeding 400 patents and serves major global biopharma organizations across drug development and clinical research applications.

Sector: Telecoms
Market: AIM

Identifiers

Ticker: AIM:PRM
Market: AIM
ISIN: GB0003104196

Learn more on:

Official site

Timeline

Proteome Sciences wins chemoproteomics contract ahead of new clinical trial

More in Telecoms

Market Brief: easyJet rejects Castlelake takeover bids, BATM Advanced Communications, Ondine Biomedical, Babcock International, Synthomer

Maintel fundraising clears final conditions ahead of admission

BATM Advanced Communications sells non-core subsidiaries in $37m deal

Fusion Antibodies receives Canadian patent allowance for antibody library technology

Tech Today: CML Microsystems near breakeven on second-half recovery, Oxford Metrics, Tristel

Tristel names Chris Lee as CEO from August

Fusion Antibodies wins InnovateUK grant to humanise DR5 antibody

Tech Today: Pennant wins C$35m Canadian Navy contract, Pri0r1ty Intelligence, MedPal AI

UK approval for first oral GLP-1 weight-loss pill will open private market opportunity, MedPal tells investors

Aeorema Communications boosted by Climate Week NYC contract

Tech Today: Light Science secures assembly deal, Vodafone Greece, Beeks Financial Cloud

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer